Tratamento de episódios maníacos e mistos

Autores

  • Doris Hupfeld Moreno Médica pesquisadora do Programa de Transtornos Afetivos (GRUDA) do Departamento e Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Doutora em Medicina pelo Departamento de Psiquiatria da FMUSP
  • Ricardo Alberto Moreno Médico coordenador do Programa de Transtornos Afetivos (GRUDA) do Departamento e Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Doutor em Medicina pelo Departamento de Psiquiatria da FMUSP

DOI:

https://doi.org/10.25118/2763-9037.2011.v1.1429

Palavras-chave:

mania, transtorno bipolar, litio, anticonvulsivantes, eletroconvulsoterapia

Resumo

.

Downloads

Não há dados estatísticos.

Métricas

Carregando Métricas ...

Biografia do Autor

Doris Hupfeld Moreno, Médica pesquisadora do Programa de Transtornos Afetivos (GRUDA) do Departamento e Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Doutora em Medicina pelo Departamento de Psiquiatria da FMUSP

Ricardo Alberto Moreno, Médico coordenador do Programa de Transtornos Afetivos (GRUDA) do Departamento e Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Doutor em Medicina pelo Departamento de Psiquiatria da FMUSP

Referências

1. Altamura AC, Lietti L, Dobrea C, Benatti B, Arici C, Dell’Osso B. Mood stabilizers for patients with bipolar disorder: the state of the art. Expert Rev Neurother. 2011 Jan;11(1):85-99. DOI: https://doi.org/10.1586/ern.10.181

2. Amrollahi Z, Rezaei F, Salehi B, Modabbernia AH, Ma-roufi A, Esfandiari GR, Naderi M, Ghebleh F, Ahmadi--Abhari SA, Sadeghi M, Tabrizi M, Akhondzadeh S. Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen ad-junctive to lithium in acute bipolar mania. J Affect Di-sord. 2011 Mar;129(1-3):327-31. DOI: https://doi.org/10.1016/j.jad.2010.08.015

3. Baldaçara L, Sanches M, Cordeiro DC, Jackoswski AP. Rapid tranquilization for agitated patients in emer-gency psychiatric rooms: a randomized trial of olanza-pine, ziprasidone, haloperidol plus promethazine, ha-loperidol plus midazolam and haloperidol alone. Rev Bras Psiquiatr. 2011 Mar;33(1):30-9. DOI: https://doi.org/10.1590/S1516-44462011000100008

4. Bertschy G, Gervasoni N, Favre S, Liberek C, Ragama--Pardos E, Aubry JM,

5. Gex-Fabry M, Dayer A. Frequency of dysphoria and mixed states. Psychopathology. 2008;41(3):187-93. DOI: https://doi.org/10.1159/000120987

6. Cipriani A, Rendell JM, Geddes JR. Haloperidol alone or in combination for acute mania. Cochrane Database Syst Rev 2006; 3: CD004362. DOI: https://doi.org/10.1002/14651858.CD004362.pub2

7. Demetrio FN, Soares OT. Interações Medicamentosas em Psiquiatria. Condutas em psiquiatria: consulta rápi-da .1.ed. Porto Alegre: Artmed, 2008; pp. 211-276.

8. Fountoulakis KN, Vieta E. Treatment of bipolar di-sorder: a systematic review of available data and cli-nical perspectives. Int J Neuropsychopharmacol. 2008 Nov;11(7):999-1029. DOI: https://doi.org/10.1017/S1461145708009231

9. Goldberg JF, Perlis RH, Bowden CL, Thase ME, Miklo-witz DJ, Marangell LB, Calabrese JR, Nierenberg AA, Sa-chs GS. Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2009 Feb;166(2):173-81. DOI: https://doi.org/10.1176/appi.ajp.2008.08050746

10. Kapczinski F, Dias VV, Kauer-Sant’Anna M, Brietzke E, Vázquez GH, Vieta E, Berk M. The potential use of bio-markers as an adjunctive tool for staging bipolar disor-der. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1366 -71. DOI: https://doi.org/10.1016/j.pnpbp.2009.07.027

11. Lafer B, Nery FG, Brietzke E. Estabilizadores do humor. In: Clínica Psiquiátrica. Eds. Miguel EC, Gentil V, Gattaz W. Ed. Manole, São Paulo, 2011.

12. Macedo-Soares MB, Moreno DH. Comorbidades. In: Da Psicose Maníaco-Depressiva ao Espectro Bipolar. Orgs. Moreno, RA e Moreno DH. 3.ed., São Paulo, Seg-mento Farma, 2008.

13. Macedo-Soares MB, Moreno RA, Rigonatti SP, Lafer B. Efficacy of electroconvulsive therapy in treatment--resistant bipolar disorder: a case series. J ECT 2005; 21: 31-34. DOI: https://doi.org/10.1097/01.yct.0000148621.88104.f1

14. Malhi GS, Adams D, Lampe L, Paton M, O’Connor N, Newton LA, Walter G, Taylor A, Porter R, Mulder RT, Berk M; Northern Sydney Central Coast Mental He-alth Drug & Alcohol; NSW Health Clinical Redesign Program; CADE Clinic, University of Sydney. Clinical practice recommendations for bipolar disorder. Acta Psychiatr Scand Suppl. 2009;(439):27-46. DOI: https://doi.org/10.1111/j.1600-0447.2009.01383.x

15. Marchetti RL. Terapêutica dos transtornos mentais as-sociados à epilepsia. Condutas em psiquiatria: consulta rápida .1.ed. Porto Alegre: Artmed, 2008; pp. 275-300.

16. Melzer-Ribeiro DL, Teng CT. Emergências psiquiátricas no hospital geral. In: Clínica Psiquiátrica. Eds. Miguel EC, Gentil V, Gattaz W. Ed. Manole, São Paulo, 2011.

17. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011 Mar;68(3):241-51. DOI: https://doi.org/10.1001/archgenpsychiatry.2011.12

18. Moreno DH, Dias RS. Epidemiologia. In: Da Psicose Maníaco-Depressiva ao Espectro Bipolar. Orgs. Mo-reno, RA e Moreno DH. 3.ed., São Paulo, Segmento Farma, 2008.

19. Moreno DH, Moreno RA. Lítio. In: Cordás TA, More-no RA (eds.). Condutas em psiquiatria: consulta rápida .1.ed. Porto Alegre: Artmed, 2008; pp. 145-162.

20. Moreno RA, Moreno DH, Soares MBM, Ratzke R. An-ticonvulsivantes e antipsicóticos no tratamento do transtorno bipolar. Rev Bras Psiquiatr 2004; 26 (suppl. 3): 37-43. DOI: https://doi.org/10.1590/S1516-44462004000700009

21. Mukherjee S, Sackeim HA, Schnur DB. Electroconvul-sive therapy of acute manic episodes: a review of 50 years’ experience. Am J Psychiatry 1994; 15: 169-176. DOI: https://doi.org/10.1176/ajp.151.2.169

22. Ng F, Mammen OK, Wilting I, Sachs GS, Ferrier IN, Cas-sidy F, Beaulieu S,

23. Yatham LN, Berk M; International Society for Bipolar Disorders. The International Society for Bipolar Disor-ders (ISBD) consensus guidelines for the safety moni-toring of bipolar disorder treatments. Bipolar Disord. 2009 Sep;11(6):559-95. DOI: https://doi.org/10.1111/j.1399-5618.2009.00737.x

24. Reinares M, Colom F, Rosa AR, Bonnín CM, Franco C, Solé B, Kapczinski F, Vieta E. The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord. 2010 Jun;123(1-3):81-6. DOI: https://doi.org/10.1016/j.jad.2009.09.009

25. Rigonatti SP, Caires MAF. Eletroconvulsoterapia. In: Cordás TA, Moreno RA (eds.). Condutas em psiquia-tria: consulta rápida .1.ed. Porto Alegre: Artmed, 2008; pp. 197-209.

26. Schwartz TL, Stahl SM. Treatment strategies for dosing the second generation antipsychotics. CNS Neurosci Ther. 2011 Apr ;17(2):110 -7. DOI: https://doi.org/10.1111/j.1755-5949.2011.00234.x

27. Schwartzmann AM, Lafer B. Diagnóstico e tratamento dos estados mistos. Rev Bras Psiq 26 2004; (supl. III): 7-11 . DOI: https://doi.org/10.1590/S1516-44462004000700003

28. Sekhar S, Kalra B, Mendhekar DN, Tekur U. Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study. J Clin Pharmacol. 2010 Jun;50(6):688-92. DOI: https://doi.org/10.1177/0091270009347870

29. Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D. Acute bipolar mania: a systematic review and meta--analysis of co-therapy vs. monotherapy. Acta Psychia-tr Scand. 2007 Jan;115(1):12-20. DOI: https://doi.org/10.1111/j.1600-0447.2006.00912.x

30. Suppes T, Eudicone J, McQuade R, Pikalov A 3rd, Carl-son B. Efficacy and safety of aripiprazole in subpopula-tions with acute manic or mixed episodes of bipolar I disorder. J Affect Disord. 2008 Apr;107(1-3):145-54. DOI: https://doi.org/10.1016/j.jad.2007.08.015

31. Swann AC, Steinberg JL, Lijffijt M, Moeller GF. Conti-nuum of depressive and manic mixed states in patients with bipolar disorder: quantitative measurement and clinical features. World Psychiatry. 2009 Oct;8(3):166-72. DOI: https://doi.org/10.1002/j.2051-5545.2009.tb00245.x

32. Szegedi A, Zhao J, van Willigenburg A, Nations KR, Mackle M, Panagides J. Effects of asenapine on depres-sive symptoms in patients with bipolar I disorder ex-periencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials. BMC Psychiatry 2011 Jun 20;11:101. DOI: https://doi.org/10.1186/1471-244X-11-101

33. Tamayo JM, Zarate CA Jr, Vieta E, Vázquez G, Tohen M. Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I di-sorder phases: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2010 Jul;13(6):813-32. DOI: https://doi.org/10.1017/S1461145709991246

34. Valentí M, Benabarre A, García-Amador M, Molina O, Bernardo M, Vieta E. Electroconvulsive therapy in the treatment of mixed states in bipolar disorder. Eur Psychiatry. 2008 Jan;23(1):53-6. DOI: https://doi.org/10.1016/j.eurpsy.2007.10.011

35. Wagner KD, Kowatch RA, Emslie GJ et al. A double-blind, randomized, placebo-controlled trial of ox-carbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry 2006; 163: 1179 –118 6 . DOI: https://doi.org/10.1176/appi.ajp.163.7.1179

36. Yildiz A, Vieta E, Leucht S, Baldessarini RJ. Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology. 2011 Jan;36(2):375-89. DOI: https://doi.org/10.1038/npp.2010.192

Downloads

Publicado

2011-12-23

Como Citar

1.
Moreno DH, Moreno RA. Tratamento de episódios maníacos e mistos. Debates em Psiquiatria [Internet]. 23º de dezembro de 2011 [citado 24º de abril de 2025];1(6):6-19. Disponível em: https://revistardp.org.br/revista/article/view/1429

Edição

Seção

Artigos Originais

Plaudit

Artigos mais lidos do(s) mesmo(s) autor(es)